142 related articles for article (PubMed ID: 19383735)
1. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents.
Niccoli G; Schiavino D; Belloni F; Ferrante G; La Torre G; Conte M; Cosentino N; Montone RA; Sabato V; Burzotta F; Trani C; Leone AM; Porto I; Pieroni M; Patriarca G; Crea F
Eur Heart J; 2009 Jun; 30(11):1340-7. PubMed ID: 19383735
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
3. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
Harjai KJ; Orshaw P; Boura J; Sporn D
Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation.
Delhaye C; Maluenda G; Wakabayashi K; Ben-Dor I; Lemesle G; Collins SD; Syed AI; Torguson R; Kaneshige K; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2010 Mar; 105(6):826-32. PubMed ID: 20211326
[TBL] [Abstract][Full Text] [Related]
5. [Role of eosinophil granulocytes in the occurrence of restenosis in patients after coronary stenting with drug-eluting stents].
Gabbasov ZA; Kozlov SG; Imaeva AÉ; Saburova OS; Masenko VP
Ter Arkh; 2014; 86(9):90-6. PubMed ID: 25518512
[TBL] [Abstract][Full Text] [Related]
6. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of eosinophil cationic protein levels with clinical symptoms and laboratory findings of patients with cystic echinococcosis].
Cicioğlu Aridoğan B; Kaya S; Sesli Cetin E; Taş T; Demirci M
Mikrobiyol Bul; 2009 Apr; 43(2):285-92. PubMed ID: 19621614
[TBL] [Abstract][Full Text] [Related]
8. In-stent restenosis after revascularization of myocardium with drug-eluting stents is accompanied by elevated level of blood plasma eosinophil cationic protein.
Gabbasov ZA; Kozlov SG; Imaeva AE; Saburova OS; Zykov KA; Masenko VP; Smirnov VN
Can J Physiol Pharmacol; 2011 Jun; 89(6):413-8. PubMed ID: 21751895
[TBL] [Abstract][Full Text] [Related]
9. Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein.
Niccoli G; Calvieri C; Minelli S; Copponi G; Montone RA; Imaeva A; Roberto M; Cosentino N; Crea F
Atherosclerosis; 2014 Dec; 237(2):816-20. PubMed ID: 25463127
[TBL] [Abstract][Full Text] [Related]
10. Predictors of in-stent restenosis and patient outcome after percutaneous coronary intervention in patients with diabetes mellitus.
Sukhija R; Aronow WS; Sureddi R; Aleti S; Molavi B; Sachdeva R; Mehta JL
Am J Cardiol; 2007 Sep; 100(5):777-80. PubMed ID: 17719319
[TBL] [Abstract][Full Text] [Related]
11. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
[TBL] [Abstract][Full Text] [Related]
12. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.
Rabbitts JA; Nuttall GA; Brown MJ; Hanson AC; Oliver WC; Holmes DR; Rihal CS
Anesthesiology; 2008 Oct; 109(4):596-604. PubMed ID: 18813037
[TBL] [Abstract][Full Text] [Related]
13. Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents.
Kim YH; Park DW; Lee SW; Yun SC; Lee CW; Hong MK; Park SW; Seung KB; Gwon HC; Jeong MH; Jang Y; Kim HS; Seong IW; Park HS; Ahn T; Chae IH; Tahk SJ; Chung WS; Park SJ;
Circulation; 2009 Aug; 120(5):400-7. PubMed ID: 19620506
[TBL] [Abstract][Full Text] [Related]
14. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil cationic protein and clinical outcome after bare metal stent implantation.
Niccoli G; Sgueglia GA; Conte M; Cosentino N; Minelli S; Belloni F; Trani C; Sabato V; Burzotta F; Porto I; Leone AM; Schiavino D; Crea F
Atherosclerosis; 2011 Mar; 215(1):166-9. PubMed ID: 21183182
[TBL] [Abstract][Full Text] [Related]
19. Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization.
Susen S; Sautière K; Mouquet F; Cuilleret F; Chmaït A; McFadden EP; Hennache B; Richard F; de Groote P; Lablanche JM; Dallongeville J; Bauters C; Jude B; Van Belle E
Eur Heart J; 2005 Nov; 26(22):2387-95. PubMed ID: 16105849
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction.
Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ;
Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
